Annals of Pharmacotherapy · 1993 · 16 citations · 8 references
PharmacyPharmacologyPharmacotherapyNeuropharmacologyPsychiatric PharmacotherapyPsychopharmacologyAntipsychotic PharmacologyAntipsychotic PharmacotherapyAntipsychotic TherapySchizophrenia PharmacotherapyAntipsychotic Medication ManagementClozapine PharmacologyGranulocyte Colony-stimulating Factor AdministrationGranulocyte Colony-stimulating Factor MobilizationGranulocyte Colony-stimulating Factor MonitoringGranulocyte-macrophage Colony-stimulating Factor Mobilization
OBJECTIVE: To report a case of clozapine- and molindone-induced agranulocytosis and to discuss treatment using filgrastim, a granulocyte colony-stimulating factor. CASE SUMMARY: A 64-year-old woman who had been on long-term clozapine therapy for schizophrenia was hospitalized with presumed drug-induced agranulocytosis. She had also been on short-term molindone therapy. A bone marrow biopsy and the initial white blood cell (WBC) count were consistent with drug-induced agranulocytosis. Following seven days of treatment with subcutaneous filgrastim 300 micrograms/d, her absolute neutrophil count was above 500 x 10(6)/L. DISCUSSION: Reports in the literature discussing antipsychotic drug-induced agranulocytosis are reviewed. A relationship between treatment with filgrastim and WBC response is postulated. CONCLUSIONS: Filgrastim may be useful in ameliorating the effects of clozapine- and molindone-induced agranulocytosis.
8
Clozapine for the Treatment-Resistant Schizophrenic
John M. Kane · Archives of General Psychiatry · 1988 · 4.1K citations
Medicine, Pharmacology, Psychiatry +16
Janice Gabrilove, Ann A. Jakubowski, Howard I. Scher et al. · New England Journal of Medicine · 1988 · 953 citations
Meyler's Side Effects of Drugs
A Breckenridge · BMJ · 1976 · 695 citations · Full text
The Risks and Benefits of Clozapine versus Chlorpromazine
James L. Claghorn, Gilbert Honigfeld, F.S. Abuzzahab et al. · Journal of Clinical Psychopharmacology · 1987 · 304 citations